Sociedad Americana de Hirudoterapia

Replantation of pediatric scalp avulsions

Case series published in J Craniofac Surg (2022)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosGur et al. · The Journal of craniofacial surgery, 2022

Abstract

Scalp avulsions are rare but can be quite morbid clinical manifestations. Pediatric patients are different from adults as they have not completed their physical, sexual, educational, or psychosocial development. Therefore, the devastation of a failed scalp replantation is much greater on these individuals, their whole future lives, and families. We present 2 consecutive pediatric cases retrospectively with the youngest successful replanted patient in Turkey and describe technical tips according to our experience.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultHumansChildScalpRetrospective StudiesMicrosurgeryAnastomosis, SurgicalAmputation, Traumatic

Resumen

Pediatric scalp avulsion replantation case series with microsurgical technique considerations.

Por qué esto importa para la hirudoterapia

This retrospective article presents two consecutive pediatric scalp avulsion cases managed with replantation, including the youngest successfully replanted patient in Turkey, with technical tips based on the authors' experience. The abstract emphasizes differences between pediatric and adult patients and the heightened psychosocial stakes of failed replantation in children. There is no mention of leeches, hirudotherapy, hirudin, or any leech-derived substance in the abstract. Although leech therapy can be used adjunctively in replantation surgery, this article does not document such use. The article has no direct relevance to ASH's research domain.

Citación

Replantation of pediatric scalp avulsions.

Gur et al. · The Journal of craniofacial surgery, 2022

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.